REQUEST A QUOTE  CART(0)
Products for Quality Control
Products
Home > Products
Cilostazol USP Related Compound C
QCC Cat No.: QC121502
Chemical Name: Cilostazol USP Related Compound C
Synonyms: 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-1-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butyl)-3,4-dihydroquinolin-2(1H)-one
CAS No.: 865792-18-3
Molecular Formula: C31H45N9O2
Molecular Weight: 575.75
================================================
Standard Reference Material For "Cilostazol USP Related Compound C"
Warning:The form of the product salt may be different from the official website,please consult your local agent for details.
RELATED PRODUCTS
QCC CAT# COMPOUND ORDER
  • QC121517
    Cilostazol Impurity 17
    CAS# 934533-79-6
    M.F.: C29H34N6O4
    M.W.: 530.63
  • QC121516
    Cilostazol Impurity 16
    CAS# NA
    M.F.: C11H19N7
    M.W.: 249.32
  • QC121510
    Cilostazol Impurity 10
    CAS# 54197-64-7
    M.F.: C10H11NO2
    M.W.: 177.20
  • QC121500
    Cilostazol
    CAS# 73963-72-1
    M.F.: C20H27N5O2
    M.W.: 369.46
  • QC121508
    Cilostazol Impurity 8
    CAS# NA
    M.F.: C29H32N6O4
    M.W.: 528.60
  • QC121509
    Cilostazol Impurity 9
    CAS# 1797509-92-2;1797008-74-2 (Na Salt)
    M.F.: C20H29N5O3
    M.W.: 387.48
  • QC121515
    Cilostazol Impurity 15
    CAS# 1796891-27-4
    M.F.: C29H34N6O4
    M.W.: 530.62
  • QC121507
    Cilostazol Impurity 7
    CAS# 73963-46-9
    M.F.: C19H23N5O2
    M.W.: 353.42
  • QC121506
    Cilostazol Impurity 6
    CAS# 87153-06-8
    M.F.: C20H27N5O3
    M.W.: 385.46
  • QC121505
    Cilostazol Impurity 5
    CAS# 73963-42-5
    M.F.: C11H19ClN4
    M.W.: 242.75
  • QC121504
    Cilostazol USP Related Compound A
    CAS# 54197-66-9
    M.F.: C9H9NO2
    M.W.: 163.17
  • QC121503
    4'-trans-Hydroxy Cilostazol
    CAS# 87153-04-6
    M.F.: C20H27N5O3
    M.W.: 385.46
  • QC121501
    Cilostazol USP Related Compound B
    CAS# 73963-62-9
    M.F.: C20H25N5O2
    M.W.: 367.44
    • DISCLAIMER | PRIVACY POLICY | TERMS OF USE
    © QUALITY CONTROL CHEMICALS INC. ALL RIGHTS RESERVED.